Dr Albert Lladó: 'We need to acknowledge the work caregivers carry out'

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
Alzheimer, drugs, Diagnosis, Treatment, Research

An interview with Dr Albert Lladó, neurologist at the Alzheimer's and other Cognitive Disorders Unit. Dr Lladó treats dementias, including Alzheimer's, which is the most common. Here we will talk ab...

IMIDomics, a Vall d'Hebron spin-off, raises $16.5 million to develop new drugs against immunomediated inflammatory diseases

by Vall d’Hebron

3 years ago
IMIDomics, drugs, immune-mediated inflammatory diseases

This investment will allow IMIDomics to accelerate the identification of new therapeutic targets and the development of new drugs for immune-mediated inflammatory diseases (IMID), like rheumatoid arth...

Revisiting the role of Extracellular Vesicles secreted by hepatocytes in drug-induced liver injury. A PRO-EURO-DILI-NETWORK Cost Action outcome

by CIC bioGUNE

3 years ago
drugs, hepatocytes, Vesicles secreted

Idiosyncratic drug-induced liver injury (DILI) constitutes a multi-layered challenge that spans the life of the drug from pre-clinical development to clinical trials and post-marketing.

CSIC Scientists propose a new strategy to regulate the cells communication network

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

3 years ago
drugs, inhibition of tyrosine kinase, molecules, cellular processes

A study performed by researchers at the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) from the Spanish National Research Council (CSIC) in collaboration with Stony Brook University (USA) p...

Comparison between 2D and 3D Cultures

by CYTES BIOTECHNOLOGIES, SL.

3 years ago
pharmaceutical industry, drugs, test the toxicity, in vitro testing, hepatotoxins

Within the pharmaceutical industry, business firms and organizations need to test the toxicity of the drugs they create. The common method used is in vitro testing employing Primary Human Hepatocytes ...

Vall d'Hebron participates in a study that identifies 33 new genetic variants associated with bipolar disorder

by Vall d’Hebron

3 years ago
bipolar disorder, drugs

These findings open the way for research into new therapeutic targets, as well as for the study of the possibility of reusing drugs that are already used in other illnesses for the treatment of bipola...

Avacopan as a substitute for corticosteroids in the treatment of ANCA-associated vasculitis

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
Vasculitis, autoimmune diseases, ANCA, drugs, Avacopan

Vasculitis is a group of rare autoimmune diseases that, until now, have mainly been treated with corticosteroids and other immunosuppressants. Corticosteroids are effective, but they have many potenti...

Drugs approved by the FDA in 2020 reflect continuing trend of structural innovation

by CAS, a division of the American Chemical Society

4 years ago
oncology, drugs, FDA, pharmaceutical industry, molecular shape

New drug innovation remained strong in 2020. The total of 53 drugs approved represented the second-highest number of approvals in more than two decades, a positive indicator of productivity in the pha...

Research is the main tool we have against cancer

by GENESIS Biomed

4 years ago
cancer, research, diagnostics, drugs

Cancer is the second biggest cause of death throughout the world today. Every year 9.6 million people die from it, 65% of them in low- and medium-income countries. Spain shows a similar trend to other...

Researchers describe molecular mechanism involved in Huntington's neurodegeneration

by Universitat de Barcelona

4 years ago
Huntington’s disease, neurons, drugs, neurodegeneration

Protein alteration in the family of lamins causes several diseases, known as laminopathies, such as progeria or precocious ageing.

The AECC funds research into new treatment for prostate cancer

by IRB Barcelona - Instituto de Investigación Biomédica

4 years ago
testosterone, AECC, Androgen, drugs, prostate cancer

One in eight men will be diagnosed with prostate cancer at some point in their lifetime. Several treatments for this type of cancer are currently available, but the tumour develops resistance and the ...

Researcher Ramon Eritja publishes book about nucleic acids chemistry

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

4 years ago
Ramon Eritja, acids chemistry, drugs, cardiovascular, DNA, RNA

The book “Nucleic Acids Chemistry” takes the most important aspects of the methodology of oligonucleotides synthesis, that is currently expanding by the endorsement of a dozen of new medicines, su...